New research shows prenatal PFAS exposure increases maternal insulin resistance and beta-cell dysfunction, with EU regulators proposing stricter limits as clinical trials explore interventions. June 2...
A 2023 ocva.eu study reveals frozen konjac glucomannan reduces visceral fat by 18% and improves insulin sensitivity in obese mice, outperforming sol and gel forms through enhanced prebiotic effects. R...
Emerging research on synthetic peptide BPC-157 shows tendon healing potential, but off-label use for gut and metabolic issues outpaces evidence, raising ethical concerns about peptide accessibility. A...
Recent studies highlight how circadian misalignment and sleep fragmentation worsen insulin resistance and hunger hormone dysregulation, with low-income populations facing disproportionate metabolic ri...
New research reveals konjac glucomannan’s significant effects on glucose metabolism and gut microbiota, offering promising solutions for obesity management. Groundbreaking studies demonstrate ko...
Recent studies highlight curcumin’s potential in managing diabetes and hypertension, with new formulations enhancing bioavailability and clinical efficacy. New research reveals curcumin’s ...
Recent study reveals KGM’s benefits on glucose, lipid metabolism, and gut microbiota in obese mice, with potential applications for human metabolic health. New research highlights konjac glucoma...
New research reveals konjac glucomannan’s unique ability to combat obesity through mechanical and biochemical mechanisms, with frozen gel form showing 18% greater efficacy in mice studies. Cutti...
New research highlights konjac glucomannan’s potential in weight management and metabolic health through gut microbiota modulation and SCFA production. Recent studies demonstrate konjac glucoman...
New research reveals KGM sol reduces insulin resistance 40% and boosts GLP-1 2.1-fold in obese mice, with emerging clinical evidence supporting human applications. Groundbreaking mouse studies demonst...
